PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 14 filers reported holding PTC THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $8,071,000 | -69.6% | 8,067,000 | -65.0% | 7.78% | -63.4% |
| Q3 2018 | $26,578,000 | -5.5% | 23,067,000 | -17.8% | 21.23% | -30.2% |
| Q2 2018 | $28,135,000 | -35.7% | 28,067,000 | -39.7% | 30.42% | +13.5% |
| Q1 2018 | $43,752,000 | +19.2% | 46,567,000 | +2.2% | 26.79% | +23.4% |
| Q4 2017 | $36,690,000 | – | 45,567,000 | – | 21.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 24,877,000 | $25,902,000 | 1.06% |
| PFM Health Sciences, LP | 19,807,000 | $20,605,000 | 0.61% |
| Partner Investment Management, L.P. | 193,000 | $201,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,430,000 | $4,581,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 20,454,000 | $21,253,000 | 0.27% |
| FARALLON CAPITAL MANAGEMENT LLC | 24,176,000 | $25,210,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,300,000 | $2,381,000 | 0.07% |
| Verition Fund Management LLC | 1,415,000 | $1,472,000 | 0.04% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 4,298,000 | $4,470,000 | 0.03% |
| LOOMIS SAYLES & CO L P | 248,482 | $8,404,000 | 0.02% |